药物发现导论 / Introduction to Drug Discovery

药物发现导论 / Introduction to Drug Discovery

第一部分：历史回顾与范式演变 / Historical Review and Paradigm Shifts

药物发现作为人类对抗疾病的根本手段，其历史几乎与人类文明本身同样悠久。从远古时代对植物药性的懵懂探索，到现代基于分子机制的精准药物设计，这一领域经历了无数次范式革命，每一次跨越都深刻重塑了人类对生命健康的认知与掌控。理解药物发现的历史演变，不仅能够帮助我们把握当前学科发展的脉络，更能为预判未来趋势提供宝贵的参照框架。

Drug discovery, as the fundamental means by which humanity combats disease, has a history nearly as long as civilization itself. From ancient peoples' rudimentary exploration of herbal medicinal properties to modern precision drug design based on molecular mechanisms, this field has undergone countless paradigm revolutions, each profoundly reshaping our understanding and control of life and health. Understanding the historical evolution of drug discovery not only helps us grasp the trajectory of current disciplinary development but also provides valuable reference for anticipating future trends.

1.1 远古至前现代时期：经验医学的漫长积累 / From Antiquity to Pre-Modern Era: The Long Accumulation of Empirical Medicine

在文字出现之前的漫长岁月里，人类通过反复试错，逐步积累了对天然药物的认识。古埃及的埃伯斯纸草文稿（Ebers Papyrus）成书于公元前1550年前后，记载了超过700种药物配方，涵盖植物、动物和矿物来源的药材。其中已经包含了柳树皮（含有水杨酸前体物质）的使用记载，这比西方现代医学确认水杨酸的疗效提前了三千余年。古埃及人还发现了没药（Myrrh）具有防腐抗菌特性，并将其用于伤口处理和木乃伊制作。

During the long millennia before the advent of writing, humanity gradually accumulated knowledge of natural pharmaceuticals through repeated trial and error. The Ebers Papyrus of ancient Egypt, written around 1550 BCE, documents over 700 drug formulations encompassing plant, animal, and mineral sources. Notably, it contains references to willow bark (which contains salicylic acid precursors), predating Western modern medicine's confirmation of salicylic acid's efficacy by over three thousand years. Ancient Egyptians also discovered the antiseptic properties of myrrh, using it for wound treatment and mummification.

中国传统医学体系代表了另一条独立发展的经验医学路径。从《神农本草经》（约成书于公元前1世纪至公元1世纪）到唐代孙思邈的《千金方》，再到明代李时珍的《本草纲目》（1578年），中国药物学形成了以性味归经、君臣佐使为理论框架的独特体系。《本草纲目》收载药物1892种，详细记载了药物的来源、性状、炮制方法和临床应用，其中许多知识至今仍具有科学价值。例如，书中记载的青蒿（Artemisia annua）用于治疗疟疾相关症状，为屠呦呦团队后来提取青蒿素提供了重要的文献线索。

Traditional Chinese Medicine (TCM) represents an independent pathway of empirical medical development. From the *Shen Nong Ben Cao Jing* (compiled between 1st century BCE and 1st century CE) to Sun Simiao's *Bei Ji Qian Jin Yao Fang* during the Tang Dynasty, and finally to Li Shizhen's *Compendium of Materia Medica* (1578 CE), Chinese pharmacology developed a unique theoretical framework based on properties, flavors, meridian tropism, and the monarch-minister-assistant-courier principle of formula construction. The *Compendium of Materia Medica* documents 1,892 drugs, providing detailed descriptions of their sources, characteristics, processing methods, and clinical applications—many of which retain scientific value to this day. For instance, the book's记载 of qinghao (Artemisia annua) for treating malaria-related symptoms provided crucial literature clues for Tu Youyou's team in their subsequent extraction of artemisinin.

值得注意的是，经验医学时期的核心特征是表型筛选（Phenotypic Screening）的原始形态——即通过观察整体反应来评价药物效果，而不深究其作用机制。这种"知其然不知其所以然"的研究范式，限制了药物发现的效率和可重复性，但也为现代药物化学提供了丰富的化合物库。至今，美国食品药品监督管理局（FDA）批准的相当比例的小分子药物仍然源于天然产物或其衍生物，天然产物在新药发现中的贡献不可替代。

It is noteworthy that the defining characteristic of empirical medicine's original form of phenotypic screening—evaluating drug effects through observing whole-organism responses without understanding underlying mechanisms—limited the efficiency and reproducibility of drug discovery but also provided a rich compound library for modern medicinal chemistry. To this day, a significant proportion of small-molecule drugs approved by the U.S. Food and Drug Administration (FDA) still originate from natural products or their derivatives, underscoring the irreplaceable contribution of natural products to new drug discovery.

1.2 19世纪至20世纪中叶：从经验到科学的转折 / From 19th Century to Mid-20th Century: The Transition from Experience to Science

19世纪标志着药物发现从经验积累向科学实证的根本转变。1804年，药剂师弗里德里希·瑟特纳（Friedrich Sertürner）从鸦片中分离出吗啡（Morphine），这是人类历史上首次从植物中提取获得纯化的活性成分。这一里程碑事件开创了天然产物化学（Natural Product Chemistry）的新纪元，预示着药物发现将逐步摆脱经验主义的束缚，走向基于化学实体的理性研究道路。

The 19th century marked a fundamental transformation in drug discovery from empirical accumulation to scientific validation. In 1804, pharmacist Friedrich Sertürner isolated morphine from opium—the first time in human history that a pure active ingredient was extracted from a plant. This milestone inaugurated a new era of natural product chemistry, signaling that drug discovery would gradually break free from the constraints of empiricism and move toward rational research based on chemical entities.

随后几十年间，一系列重要活性成分相继被分离鉴定：1820年从金鸡纳树皮中提取奎宁（Quinine）用于疟疾治疗；1828年从甜菜中分离出甜菜碱；1833年从颠茄中提取阿托品（Atropine）。这些成就不仅为临床提供了有效治疗药物，更重要的是建立了分离-纯化-活性验证的研究范式，为后续药物化学的发展奠定了方法论基础。

Over the following decades, a series of significant active ingredients were isolated and characterized: quinine extracted from cinchona bark in 1820 for malaria treatment; betaine isolated from sugar beets in 1828; atropine from belladonna in 1833. These achievements not only provided effective therapeutic drugs for clinical use but, more importantly, established the research paradigm of isolation-purification-activity verification, laying methodological foundations for subsequent pharmaceutical chemistry development.

进入20世纪，两项革命性突破从根本上改变了药物发现的格局。

Two revolutionary breakthroughs in the 20th century fundamentally transformed the landscape of drug discovery.

第一项突破是化学治疗（Chemotherapy）概念的建立。1908年，保罗·埃尔利希（Paul Ehrlich）提出"魔法子弹"（Magic Bullet）理论——理想的治疗药物应该像精确制导的子弹一样，选择性地作用于病原体而不伤害宿主。这一理论催生了系统性筛选化合物的思想，为现代药物化学和毒理学奠定了概念基础。埃尔利希本人也于1909年发现了砷凡纳明（Salvarsan），成为第一个成功治疗梅毒的有机合成药物。

The first breakthrough was the establishment of the chemotherapy concept. In 1908, Paul Ehrlich proposed the "magic bullet" theory—the ideal therapeutic agent should act like a precision-guided missile, selectively targeting pathogens without harming the host. This theory gave rise to the idea of systematically screening compounds, laying the conceptual foundation for modern pharmaceutical chemistry and toxicology. Ehrlich himself discovered Salvarsan (arsphenamine) in 1909, the first organically synthesized drug successfully used to treat syphilis.

第二项突破是抗生素革命（Antibiotic Revolution）。1928年，亚历山大·弗莱明（Alexander Fleming）意外发现青霉菌（Penicillium notatum）产生的某种物质能够抑制金黄色葡萄球菌的生长，他将这种物质命名为青霉素（Penicillin）。然而，青霉素作为临床药物的真正开发发生在十年之后。霍华德·弗洛里（Howard Florey）和恩斯特·钱恩（Ernst Chain）在牛津大学的工作解决了青霉素的分离、纯化和大规模生产问题，使其在1940年代成为二战中拯救无数伤兵的"救命药"。青霉素的成功不仅开创了抗生素时代，更重要的是证明了微生物发酵（Microbial Fermentation）可以成为大规模生产药物的有效途径。

The second breakthrough was the antibiotic revolution. In 1928, Alexander Fleming accidentally discovered that a substance produced by the mold Penicillium notatum could inhibit the growth of Staphylococcus aureus, naming it penicillin. However, the true clinical development of penicillin occurred a decade later. Howard Florey and Ernst Chain at Oxford University solved the problems of penicillin's isolation, purification, and large-scale production, transforming it into a "life-saving drug" that saved countless soldiers during World War II in the 1940s. The success of penicillin not only inaugurated the antibiotic era but, more importantly, demonstrated that microbial fermentation could serve as an effective pathway for large-scale drug production.

青霉素之后，链霉素（Streptomycin，1943年）、氯霉素（Chloramphenicol，1947年）、红霉素（Erythromycin，1952年）等抗生素相继被发现并应用于临床。这些成就使感染性疾病从"死亡判决"转变为可治愈的普通疾病，深刻改变了人类疾病的谱系分布。

Following penicillin, antibiotics such as streptomycin (1943), chloramphenicol (1947), and erythromycin (1952) were successively discovered and applied clinically. These achievements transformed infectious diseases from "death sentences" into curable common ailments, profoundly altering the distribution of human disease patterns.

1.3 20世纪下半叶：分子药理学的兴起 / Late 20th Century: The Rise of Molecular Pharmacology

20世纪后半叶见证了药物发现范式的另一场深刻变革：分子靶点（Molecular Target）概念的确立和基于靶点的理性药物设计（Rational Dru